Oramed Pharma (ORMP) Announces 2.89M Unit Registered Direct Offering at $6.25/Unit
Tweet Send to a Friend
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced today that it has entered into definitive agreements with several healthcare-focused institutional investors for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE